Some sulphonium salts derived from lysine were synthesized with the general structure R-Lys-CH2S -(alkyl)2. They were examined as inhibitors of the cysteine proteinase clostripain, which has a preference for cleaving peptide bonds at the carboxy group of basic amino acids, and of a number of trypsin-related serine proteinases. Clostripain was irreversibly inactivated by all reagents examined, but in the case of the serine proteinases, depending on the reagent structure, irreversible and reversible inhibitions were observed. These were kinetically characterized.
INTRODUCTION
Peptidylmethanesulphonium salts of the general structure R-CO-CH2S+(CH3)2 were viewed as promising affinity-labelling reagents for proteinases in view of the widespread function of S-adenosylmethionine as an enzymically guided alkylating agent. Initial observations with peptides containing hydrophobic side chains such as Cbz-Phe-Ala-CH2S+(CH2)2 showed considerable effectiveness for the inactivation of cathepsin B by transfer of the peptidylmethyl group rather than by methylation (Shaw, 1988) . In fact, the active form of the agent may not be the sulphonium salt, but the derived ylide, in view of the increasing effectiveness with increasing pH.
Derivatives containing basic side chains were then synthesized and examined. Cbz-Lys-CH2S+(CH3)2 was found to have no effect at 0.1 mm on trypsin and related enzymes, giving the impression that this type of inhibitor might be effective only on cysteine proteinases (Walker & Shaw, 1985) . However, the properties of the dipeptide derivatives such as Cbz-Phe-Lys-CH2S+(CH3)2 reported in the present paper indicate that the pattern of responses of the two classes of proteinases is more complex.
EXPERIMENTAL Materials
Trypsin (tosylphenylanalylchloromethane-treated) was purchased from Worthington Biochemicals Corp., Freehold, NJ, U.S.A.; plasmin (human) and clostripain were from Boehringer, Mannheim, West Germany; plasma kallikrein was from Kabi-Vitrum, Stockholm, Sweden. Fluorogenic substrates were obtained from Bachem Chemicals, Bubendorf, Switzerland. Syntheses Cbz-Lys(-Boc)-CH2Br. This was prepared from the diazomethyl ketone as described for the chloro compound (Coggins et al., 1974) and obtained as crystals, m.p. 68-69°C, from ethyl acetate/hexane (Found: C, 52.57; H, 6.42; N, 6.24; Br, 17.24. Calc. for C20H29BrN205 (457.4) : C, 52.52; H 6.39; N, 6.13; Br,  
17.470).
Cbz-Lys(-Boc)-CH2S-CH2Ph. The foregoing bromomethyl ketone (4.5 g) in methanol (80 ml) was stirred at room temperature for 2 h with sodium methoxide (0.56 g) and benzyl mercaptan (1.2 ml). After removal of methanol under reduced pressure, the crude product was taken up in ethyl acetate, washed with water and then aq. satd. NaHCO3, and dried. The oily residue was chromatographed on silica gel with methylene chloride/ethanol (9: 1, v/v) and eventually crystallized from ethyl acetate/ hexane. The yield was 4.34 g (88 %), m.p. [66] [67] 64.79; H, 7.39; N, 5.65; S, 6.39. Calc. for C27H26N205S (500.6): C, 64.73; H, 7.25; N, 5.59;  S, 6.40%).
Cbz-Lys(-Boc)-CH2S+(CH3}-CH2Ph,BF4-. The benzyl thioether thus obtained (670 mg) and methyl iodide (0.5 ml) were stirred in nitromethane (5 ml) with AgBF4 (260 mg) for 36 h. Methylene chloride was added and the suspension was filtered over a small volume of Fluorosil. The filtrate was concentrated and the residue treated with diethyl ether, yielding 210 mg (270) of crystals melting unsharply near 100°C (Found: C, 55.79; H, 6.57; F, 12.39; N, 4.86; S, 5.51. Calc. for C28H40BF4N205 (599.5): C, 56.02; H, 6.73; F, 12.01;  N, 4.67; S, 5.32o%).
Cbz-Lys-CH2S+(CH3)-CH2Ph,2BF4-. The t-butoxycarbonyl derivative (100 mg) in acetic acid (1.5 ml) was stirred at room temperature with BF3 etherate (80 al). The precipitate that formed was collected by centrifugation, washed with diethyl ether, and dried. The yield was 43mg, 46.91; H, 5.59; F, 25.35; N, 4.86; S, 5.53. Calc. for C23H32B2F8N203S (590.2): C, 46.80; H, 5.47; F, 25.75; N, 4.75; S, 5.43 
%).
Cbz-Lys-(Boc)-CH2S+(CH3)2,Br-.
Cbz-Lys(Boc)-CH2Br (2.0 g) in benzene (40 ml) at 50°C was treated with dimethyl sulphide (5 ml). The cooled mass was thinned with diethyl ether, and the precipitate collected and C22H35BrN205S (519.6): C, 50.86; H, 6.79; Br, 15.38; S, 6 .17%).
Cbz-Lys-CH2S+(CH3)2,CF3CO2-. The blocked salt (1 g) was treated at 0°C with methylene chloride/ trifluoroacetic acid (1:1, v/v) mixture (1O ml) for 40 min. At this time t.l.c. in chloroform/methanol (2:1, v/v) revealed complete conversion into unblocked sulphonium salt. The solvents were removed under reduced pressure.
Cbz-Phe-Lys(-Boc)-CH2Br. Cbz-Phe-OSu (1.3 g, 3.3 mmol), N-methylmorpholine (0.4 ml, 3.6 mmol) and H-Lys(-Boc)-OH (0.89 g, 3.6 mmol) were stirred in dimethylformamide (25 ml) at room temperature for 22 h. The filtrate was concentrated under reduced pressure to a syrup, which was taken up in ethyl acetate, extracted with aq. 10 % (w/v) citric acid then water, and dried with anhydrous MgSO4. The residue was crystallized from ethyl acetate/hexane, yielding 1.43 g, m.p. [108] [109] [110] 63.84; H, 6.88; N. 7.88. Calc. for C28H37N307 (527.5): C, 63.74; H, 7.07; N, 7 .95 %).
The acid (1.0 g) was converted into the diazomethyl ketone by reaction of the mixed anhydride with diazomethane (Shaw & Green, 1981) Cbz-Phe-Lys-CH2S+(CH3)-CH2Ph,BF4-. The blocked benzyl thioether above (318 mg) in nitromethane (2.5 ml) and acetone (1 ml) was treated with a solution of AgBF4 (110 mg) in nitromethane (1 ml). There was rapid precipitation. After about 3 h at room temperature the mixture was centrifuged. Examination of the supernatant solution by t.l.c. showed the absence of starting material, RF 0.7 in ethyl acetate/hexane (1: 1, v/v), and conversion into a non-migrating iodine-staining zone at the origin.
Removal of the solvent under reduced pressure left a residue, 0.38 g. This was deblocked in trifluoroacetic acid at room temperature in 15 min. Removal of the solvent and trituration of the residue with diethyl ether gave a product, 91 %0 pure by h.p.l.c.
KINETIC TECHNIQUES Inactivation studies
(1) Inactivation of plasma kallikrein with Cbz-Phe-Lys-CH2S+(CH3)2. By using the same procedure as described 0.1 LM stock solution) was added to a solution (1 ml) of Cbz-Phe-Arg-NH-Mec (100 /LM) and inhibitor (100-300 /tM) in 200 mM-Tris/HCl buffer, pH 7.8, containing 20 mM-NaCl and 1 mM-CaCl2 maintained at 37 'C. The rate of hydrolysis of substrate was monitored continuously by measuring the rate of increase of fluorescence at 455 nm (Aexe 383 nm) in a Perkin-Elmer 650-1OS spectrophotometer.
(2) Inactivation of plasma kallikrein with Cbz-Phe-LysCh2S+(CH3-CH2Ph. The same procedure was used as in the preceding subsection (1); however, the concentration range was 100-400 /tM.
(3) Inactivation of plasmin with Cbz-Phe-Lys-CH2S+(CH3)2. By using the same procedure as described in subsection (1) (6) Inactivation of clostripain with Cbz-Lys-CH2S+(CH3)2. Clostripain (1 nM) was assayed at 37 'C with PhCO-Phe-Val-Arg-NH-Mec (40 jtM) in the presence of the sulphonium salt (50-300 nM) and Tris buffer as above.
(7) Inactivation of clostripain with Cbz-Phe-Lys-CH2S+(CH3)-CH2Ph. By using the procedure described in subsection (6), clostripain (0.36 nM) was assayed in the presence of 0.5-4.0 nm inhibitor. Determination of Km and Vmax for fluorogenic substrates To determine the Km and Vmax for the substrates used in the present studies, substrate concentrations spanning the range 0.2-5 times the Km were used. For each enzyme-substrate pair studied, it was ensured that the determinations of the kinetic constants were carried out under the exact conditions used to monitor the inactivation processes described in the preceding section. The rate of substrate hydrolysis was determined by measuring the rate of increase of fluorescence at 455 nm (Amax 383 nm). Km and Vmax values were determined by using the least-squares method (Roberts, 1977 accurately determined amounts of D-Phe-Phe-ArgCH2Cl. This molarity was then related to the steady-state hydrolysis of a solution (1 ml) of PhCO-Phe-Val-Arg-NH-Mec (40 /M) in order to have a more convenient measure of enzyme concentration from day to day. Evaluation of kinetic parameters The kinetic constants for the irreversible inactivation of kallikrein, plasmin and clostripain were determined as previously described (Walker & Elmore, 1984) . In this method, data from progress curves (see, e.g., Fig. 1 ) for the hydrolysis of a suitable substrate obtained in the presence of an inhibitor are utilized to determine the inhibition constant K1 and the first-order rate constant k1 for the reaction scheme shown in Scheme 1, where E-I is the irreversibly inactivated enzyme.
The kinetic constants for the slow-binding reversible inhibition were determined essentially as described by Williams & Morrison (1979) . In this method, data from the progress curves (see, e.g., Fig. 2) for the hydrolysis of substrate in the presence of inhibitor are fitted by nonlinear regression analysis (Duggleby et al., 1982; Williams et al., 1980; Schloss et al., 1980) Analysis of the data points from progress curves in Fig. 1 by the method of Walker & Elmore (1984) yielded Morrison, 1982; Williams & Morrison, 1979) . In this reaction scheme the formation of the enzyme-inhibitor complex occurs slowly and an initial uninhibited rate for substrate hydrolysis is observed. The velocity of substrate hydrolysis gradually decreases (see Fig. 2 ) to a final inhibited rate, at which time equilibrium or steady state has been established. The association rate constant k3, the dissociation rate constant k4 and hence K. (k4/k3) for the inhibition of kallikrein by Cbz-Phe-Lys-CH2S+(CH3)-CH2Ph can be evaluated from the plot of kobs versus [I] in Fig. 3 by utilizing the relationship (see Morrison, 1982) :
Thus, Km having been determined in a separate experiment in the absence of inhibitor, k4 and k3 can be calculated from the intercept and slope respectively of the plot in Fig. 3 . 
Inhibition studies with trypsin
Incubation of trypsin with Cbz-Phe-Lys-CH2S+-(CH3)2 resulted in complete irreversible inactivation of the enzyme. The kinetic constants Ki and ki-for the inhibition process were found to be 7.1 x 10-4+ 0.8 x 10-M and 0.2 + 0.02 min-1 respectively, as evaluated by using the Kitz-Wilson method outlined in the Experimental section (Kitz & Wilson, 1962) . In comparison with this inhibitor, the corresponding S-benzyl-S-methylpeptidylmethanesulphonium salt functioned as a very poor slow-binding inhibitor. Since very high concentrations (near 1 mM) were required before any inhibition was observed, the kinetic constants for this process were not determined. The results with serine proteinases are summarized in Table 1 inactivators of clostripain, as was expected, since clostripain has a trypsin-like specificity (Porter et al., 1971) although it is a cysteine proteinase. The progress curves for the hydrolysis of PhCO-Phe-Val-Arg-NHMec in the presence of various concentrations of the dipeptide derivative are shown in Fig. 5 . Analysis of these data yielded values for Ki and k, that are given in Table 2 along with those obtained for the lysine derivative. The major feature to note is that the lysine derivative binds the enzyme before covalent-bond formation with a much higher affinity than does the dipeptide derivative; the respective K1 values are 7.8 nm and 280 nm. However, counteracting this decrease in affinity of the dipeptide derivative is the very much greater rate of alkylation of the enzyme by this derivative, i.e. 23-fold more rapidly than the lysine compound. The overall effect of these conflicting differences is that the lysine derivative is marginally the more potent inhibitor, as reflected in the second-order rate constants for the inactivation of clostripain.
Comparing the selectivity of these lysine-derived sulphonium salts with respect to the inactivation of serine or cysteine proteinases, the observations available are still limited. However, in the case of SS-dimethyl sulphonium salts the affinity of Cbz-Lys-CH2S+(CH3)2 for clostripain is in the nanomolar range (Table 2) , whereas for the more susceptible members of the trypsin family the affinities lie in a range near 10 /tM for a dipeptide derivative (Table 1 ). This comparison fortifies the impression obtained with cathepsin B (Shaw, 1988) that peptidylmethanesulphonium salts are particularly effective as cysteine proteinase inactivators. The change from SS-dimethyl to an S-benzyl-S-methyl sulphonium salt provided an unexpected example of changing the nature of the inhibition of the three serine proteinases examined from irreversible to reversible. It seems unlikely that this will be a general finding; other substituents may Vol. 250 conceivably introduce some selectivity within a closely related group of proteinases such as the trypsin-related enzymes.
